Skip to main content

Table 5 Antitumor Effects

From: Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients

 

< 70 Years (n = 14)

≥ 70 Years (n = 8)

P values*

RR (%)

60.0

50.0

0.5490

DCR (%)

100

83.3

0.3750

CR/PR/SD/PD/NE

0/6/4/0/2

0/3/2/1/1

-

  1. Abbreviation: CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; NE, not evaluable; RR, response rate (CR+PR); DCR, disease control rate (CR+PR+SD).
  2. *P values were calculated with the use of Fisher's exact probability test.
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us